Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Alpha-chymotrypsin | Starlite/ChEMBL | References |
Homo sapiens | cathepsin G | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.048 uM | Inhibitory activity against bovine pancreas alpha-chymotrypsin in vitro | ChEMBL. | 9216834 |
IC50 (binding) | = 0.048 uM | Inhibitory activity against bovine pancreas alpha-chymotrypsin in vitro | ChEMBL. | 9216834 |
IC50 (binding) | = 7 uM | Inhibitory activity against human neutrophil cathepsin G. | ChEMBL. | 9216834 |
IC50 (binding) | = 7 uM | Inhibitory activity against human neutrophil cathepsin G. | ChEMBL. | 9216834 |
IC50 (binding) | = 20 uM | Inhibitory activity against human heart chymase in vitro. | ChEMBL. | 9216834 |
IC50 (binding) | = 20 uM | Inhibitory activity against human heart chymase in vitro. | ChEMBL. | 9216834 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.